Ibex Medical Analytics (אייבקס מדיקל אנליטיקס בע"מ)

Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology. They use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist. Their Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity. Deployed worldwide, Galen is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis.

75.5logo
logo
logo
logo
logo
logo
75.5
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logologologologo
Valuation
logo
$
Valuation
Funding
logo
$
$ 55.00 M
$ 114.15 M
Funding
$ 55.00 M
$ 114.15 M
Statistics
logo
NA
Action

Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology. They use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist. Their Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity. Deployed worldwide, Galen is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis.

0and0